| Literature DB >> 35368937 |
Nansheng Liao1, Chaowei Xu1, Shuang Zheng1, Rongguo Wang1.
Abstract
The aim of this study was to investigate the effects of double-channel anastomosis versus esophagojejunostomy on postoperative recovery and complications after laparoscopic D2 radical gastrectomy for early proximal gastric cancer. The cases were collected from 100 patients with early proximal gastric cancer admitted to our hospital from January 2017 to January 2021. According to different surgical methods, they were divided into control group (total gastrectomy + esophagojejunal anastomosis) and experimental group (D2 radical resection + double-channel anastomosis). The two groups were compared in terms of clinical outcomes (operative time, intraoperative blood loss, number of lymph nodes dissected, digestive tract anastomosis time, postoperative exhaust, and hospitalization days), postoperative complications, and nutritional status; the expression of T lymphocyte subsets in peripheral blood of the two groups was detected to reflect the recovery of immune ability. There was no significant difference between the observation group and the control group in clinical operation effect indexes (P < 0.05). The incidence of complications of dumping syndrome and reflux esophagitis in the observation group was significantly lower than that in the control group (P < 0.05). In terms of postoperative nutritional status, the ratio of plasma albumin level and body weight restored to operation at 12 and 24 weeks after operation in the observation group was significantly higher than that in the control group (P < 0.05). 3 months after the operation, the levels of CD3 +, CD4 + cell subsets, and CD4+/CD8+ index reflecting the recovery of immune ability in the observation group were significantly higher than those in the observation group (P < 0.05). The application of double-channel anastomosis in laparoscopic D2 radical gastrectomy for early proximal gastric cancer has a better effect on reducing complications and promoting postoperative recovery, which is of great application value.Entities:
Mesh:
Year: 2022 PMID: 35368937 PMCID: PMC8967533 DOI: 10.1155/2022/8281558
Source DB: PubMed Journal: J Healthc Eng ISSN: 2040-2295 Impact factor: 2.682
General data between groups.
| Observation group ( | Control group ( | t/ |
| |
|---|---|---|---|---|
| Age (years) | 59.20 ± 7.81 | 58.66 ± 7.65 | 0.349 | 0.726 |
| Gender (male) | 18 | 19 | 3.313 | 0.068 |
| Tumor diameter (cm) | 2.23 ± 1.08 | 2.21 ± 1.09 | 0.092 | 0.927 |
| PT staging | ||||
| Stage 1a | 27 | 28 | 0.490 | 0.484 |
| Stage 1b | 23 | 22 | ||
| PN stage | ||||
| 0 | 21 | 20 | 0.045 | 0.977 |
| 1 | 24 | 25 | ||
| 2 | 5 | 5 | ||
| Lymphatic infiltration | ||||
| Negative | 37 | 39 | 13 | 0.486 |
| Positive | 13 | 11 | ||
Figure 1Operation of patients with early proximal gastric cancer treated by double-channel anastomosis.
Comparison of surgical indicators between the two groups (‾x ± s).
| Group |
| The operation time (min) | Anastomosis timing (min) | Number of dissected lymph nodes (n) | Intraoperative blood loss (ml) | Postoperative exhaust time (h) | Postoperative hospital stay (d) |
|---|---|---|---|---|---|---|---|
| Observation group | 50 | 74.83 ± 9.82 | 32.36 ± 7.92 | 35.05 ± 3.54 | 227.58 ± 15.38 | 2.17 ± 0.75 | 7.98 ± 0.76 |
| Control group | 50 | 76.32 ± 16.63 | 34.33 ± 5.65 | 34.09 ± 4.07 | 231.07 ± 13.38 | 2.26 ± 0.65 | 8.23 ± 0.94 |
|
| — | 0.546 | 1.432 | 1.258 | 1.211 | 0.641 | 1.462 |
|
| — | 0.587 | 0.155 | 0.211 | 0.229 | 0.523 | 0.147 |
Comparison of postoperative complications between the two groups (n, (%)).
| Group |
| Anastomotic fistula | Postoperative obstruction | Dumping syndrome | Reflux esophagitis |
|---|---|---|---|---|---|
| Observation group | 50 | 0(0.00) | 0(0.00) | 2(4.00) | 4(8.00) |
| Control group | 50 | 1(2.00) | 1(2.00) | 8(16.00) | 12(24.00) |
|
| — | 1.010 | 1.010 | 4.000 | 4.762 |
|
| — | 0.315 | 0.315 | 0.046 | 0.029 |
The nutritional status of the two groups at 3 and 6 months after operation was compared.
| Group |
| The plasma albumin level returned to preoperative | Weight regain to preoperative level | ||
|---|---|---|---|---|---|
| At 12 weeks postoperatively | At 24 weeks postoperatively | At 12 weeks postoperatively | At 24 weeks postoperatively | ||
| Observation group | 50 | 32(64.00) | 41(82.00) | 25(50.00) | 34(68.00) |
| Control group | 50 | 22(44.00) | 32(64.00) | 15(30.00) | 21(42.00) |
|
| — | 4.026 | 4.110 | 4.167 | 4.006 |
|
| — | 0.044 | 0.043 | 0.041 | 0.045 |
Comparison of peripheral blood T lymphocyte subsets between the two groups before and after operation (‾x ± s).
| Group |
| Preoperative | 3 months postoperative | ||||||
|---|---|---|---|---|---|---|---|---|---|
| CD3+ | CD4+/CD3+ | CD8+/CD3+ | CD4+/CD8+ | CD3+ | CD4+/CD3+ | CD8+/CD3+ | CD4+/CD8+ | ||
| Observation group | 50 | 56.63 ± 5.27 | 36.25 ± 4.25 | 57.27 ± 5.36 | 0.65 ± 0.15 | 70.65 ± 5.83 | 57.43 ± 4.52 | 37.45 ± 3.57 | 1.52 ± 0.12 |
| Control group | 50 | 55.28 ± 6.11 | 35.64 ± 4.75 | 60.24 ± 5.89 | 0.59 ± 0.16 | 62.45 ± 5.57 | 48.24 ± 4.11 | 42.14 ± 4.26 | 1.15 ± 0.16 |
|
| — | 0.194 | 0.246 | 0.893 | 0.257 | 5.357 | 4.854 | 5.986 | 4.986 |
|
| — | 0.125 | 0.314 | 1.032 | 0.386 | 0.015 | 0.018 | 0.012 | 0.022 |
Figure 2Flow cytometry was used to detect the changes of T lymphocyte subsets in peripheral blood of 2 groups before and after operation.